Stallergenes Greer PLC | Ownership
Companies that own Stallergenes Greer PLC
ING Belgium SA/NV (Private Banking)
169,782
0.86%
-9,884
0.09%
06/30/2018
La Garantie Mutuelle des Fonctionnaires SAM
116,108
0.59%
-699
0.01%
12/31/2015
Oddo BHF Asset Management SAS
110,161
0.56%
0
0.04%
04/30/2018
Intrepid Capital Management, Inc. (Florida)
109,276
0.55%
5,112
1.05%
03/31/2018
SMA Gestion SA
108,314
0.55%
31,546
1.09%
12/30/2016
Fidelity Management & Research Co.
105,120
0.53%
0
0%
04/30/2018
Portzamparc Gestion SA
85,638
0.43%
-5,000
0.56%
06/29/2018
The Vanguard Group, Inc.
80,294
0.41%
1,489
0%
07/31/2018
JOHCM (USA), Inc.
79,348
0.4%
11,705
0.73%
03/31/2018
Norges Bank Investment Management
76,147
0.39%
34,045
0%
12/31/2017
| Address |
40 Bernard Street
London Greater London WC1N 1LE
United Kingdom
|
|
Employees
|
- |
| Website |
http://stallergenes.co.uk |
| Updated |
09/14/2018 |
| Stallergenes Greer Plc is a healthcare company, which engages in the development and commercialization of allergy immunotherapy products and services. Its products include sublingual products, subcutaneous products, and veterinary products. It operates through the following geigraphical segments: Southern Europe; Northern and Central Europe; Internation Markets; and United States. |
